161 related articles for article (PubMed ID: 33078588)
1. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.
Chang JS; Kim N; Kim JY; Do SI; Cho Y; Kim HS; Kim YB
J Gynecol Oncol; 2020 Nov; 31(6):e78. PubMed ID: 33078588
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
[TBL] [Abstract][Full Text] [Related]
3. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
Zhou S; Liu S; Tian G; Zhao L; Wang H; Li Y; Shen Y; Han L
Gynecol Oncol; 2022 Jul; 166(1):138-147. PubMed ID: 35595569
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of kallikrein 5 as a novel prognostic biomarker in gastric adenocarcinoma.
Abuduhadeer X; Xu X; Aihesan K; Yilihamu M; Zhao Y; Zhang W
J Clin Lab Anal; 2021 Oct; 35(10):e23958. PubMed ID: 34510543
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
8. Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.
Dorn J; Magdolen V; Gkazepis A; Gerte T; Harlozinska A; Sedlaczek P; Diamandis EP; Schuster T; Harbeck N; Kiechle M; Schmitt M
Ann Oncol; 2011 Aug; 22(8):1783-90. PubMed ID: 21273346
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
12. Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
Cho WK; Kim YI; Park W; Yang K; Kim H; Cha H
Int J Gynecol Cancer; 2019 Sep; 29(7):1116-1120. PubMed ID: 31474588
[TBL] [Abstract][Full Text] [Related]
13. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
18. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
19. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
Zhang W; Hou T; Niu C; Song L; Zhang Y
PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
[TBL] [Abstract][Full Text] [Related]
20. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.
Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB
Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
